Delta-like ligands (DLLs) control Notch signaling. DLL1, DLL3 and DLL4 are frequently deregulated in cancer and influence tumor growth, the tumor vasculature and tumor immunity, which play different roles in cancer progression. DLLs have attracted intense research interest as anti-cancer therapeutics. In this review, we discuss the role of DLLs in cancer and summarize the emerging DLL-relevant targeting methods to aid future studies.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213894 | PMC |
| http://dx.doi.org/10.2147/OTT.S244860 | DOI Listing |
Publication Analysis
Top Keywords
role dlls
8
dlls cancer
8
cancer
4
cancer novel
4
novel therapeutic
4
therapeutic target
4
target delta-like
4
delta-like ligands
4
ligands dlls
4
dlls control
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!